Trajan Acquires Grale Scientific

Trajan Acquires Grale Scientific

February 28, 2012

Trajan Scientific and Medical has acquired the business of Grale Scientific. Grale, established in 1983, is a leading supplier of pathology consumables and services, based in Melbourne, Victoria, Australia. Stephen Tomisich, Director of the Trajan Group said “Grale is an ideal launching pad for Trajan in Victoria. It’s a great business built around personalized service to pathology laboratories; a strength we intend to build upon.”

The product range of Grale Scientific includes specimen containers, cutting/preparation tools, a broad range of microscope slides, coverslips, reagent products and storage solutions.

Trajan was established in August 2011 with a charter to work with, develop and invest in scientific and medical businesses.




Also in News

Interview: Why data quality plays a critical role in personalized medicine, with microsampling expert Dr Michele Protti
Interview: Why data quality plays a critical role in personalized medicine, with microsampling expert Dr Michele Protti

November 30, 2020

Trajan Scientific and Medical’s hemaPEN® microsampling technology has been developed with extensive consultation and evaluation by leading analytical laboratories, clinicians and healthcare professionals.

This month, Trajan presents an exclusive interview with researcher Dr Michele Protti of Pharmaco-Toxicological Analysis, Bologna, Italy, on the future of microsampling and the critical role hemaPEN can play when used in therapeutic drug monitoring for optimal therapy personalization.

Read More

Trajan celebrates International Pathology Day with ScyTek Laboratories to deliver quality IHC solutions
Trajan celebrates International Pathology Day with ScyTek Laboratories to deliver quality IHC solutions

November 11, 2020

In celebration of International Pathology Day, Trajan Scientific and Medical (Trajan) is proud to announce a new partnership with ScyTek Laboratories (ScyTek) to deliver quality immunohistochemistry (IHC) solutions.

Read More

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More